Hypertension 2025 Scientific Sessions  /  My Top Clinical-Practice Changing Papers this Year  /  Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial. irzepatide for the treatment of OSA and obesity
Logo

American Heart Association

  57
  0

Final ID:

Antihypertensive Medication Timing and Cardiovascular Events and Death The BedMed Randomized Clinical Trial. irzepatide for the treatment of OSA and obesity

  • Voora, Raven  ( UNC Hospital , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Raven Voora: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Mineralys Therapeutics:Active (exists now)
Meeting Info:

Hypertension 2025 Scientific Sessions

2025

Baltimore, Maryland

Session Info:

My Top Clinical-Practice Changing Papers this Year

Sunday, 09/07/2025 , 08:00AM - 08:45AM

Primary Care

More abstracts on this topic:
The Global Risk Consortium. Global effect of CV risk factors on lifetime estimates
2Saxena M, et al. Lorundrostat in participants with uncontrolled hypertension and treatment-resistant hypertension

Weir Matthew

BPROAD Research Group. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease. Nephrol Dial Transplant

Townsend Raymond

More abstracts from these authors:
Transforming Hypertension Care: The Symplicity™ Blood Pressure Procedure

Commodore-mensah Yvonne, Bloch Michael, Fulton Brian, Voora Raven

The future of HTN care is now: The Symplicity Blood Pressure Procedure

Randolph Tiffany, Bloch Michael, Fulton Brian, Voora Raven

You have to be authorized to contact abstract author. Please, Login
Not Available